Compare SCCO & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCCO | MDT |
|---|---|---|
| Founded | 1952 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.9B | 131.9B |
| IPO Year | 1996 | 2014 |
| Metric | SCCO | MDT |
|---|---|---|
| Price | $175.65 | $76.34 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 11 | 21 |
| Target Price | ★ $139.37 | $108.21 |
| AVG Volume (30 Days) | 1.3M | ★ 8.8M |
| Earning Date | 05-12-2026 | 06-03-2026 |
| Dividend Yield | 2.38% | ★ 3.58% |
| EPS Growth | 20.74 | ★ 30.80 |
| EPS | 1.92 | ★ 2.76 |
| Revenue | $6,654,500,000.00 | ★ $33,537,000,000.00 |
| Revenue This Year | $18.08 | $8.91 |
| Revenue Next Year | N/A | $6.54 |
| P/E Ratio | $97.82 | ★ $27.88 |
| Revenue Growth | ★ 23.69 | 3.62 |
| 52 Week Low | $88.73 | $74.40 |
| 52 Week High | $223.89 | $106.33 |
| Indicator | SCCO | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 34.11 |
| Support Level | $165.89 | N/A |
| Resistance Level | $221.35 | $89.01 |
| Average True Range (ATR) | 6.34 | 1.74 |
| MACD | 0.80 | -0.03 |
| Stochastic Oscillator | 33.65 | 20.16 |
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.